Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Colinz Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:531210 P/E (TTM) :39.6
ISIN Demat:INE923C01011 Div & Yield %:0 EPS (TTM) :1.01
Book Value (RS) :26.0966966 Market Cap (Rs Cr.):18.28 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Sep 2025)
Quarter Ended
(Sep 2024)
Quarter Ended
(% Var)
Sales 1.39 1.86 -25.27
Other Income 0.16 0.08 100.00
PBIDT 0.24 0.25 -4.00
Interest 0.01 0.01 0.00
PBDT 0.23 0.24 -4.17
Depreciation 0.04 0.03 33.33
PBT 0.19 0.21 -9.52
Tax 0.05 0.05 0.00
Deferred Tax 0.00 0.00 0.00
PAT 0.14 0.16 -12.50

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)